Research Library / Article Summary

Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models

Plain-English AddictionTube research summary with source link, DOI, key finding, and recovery relevance.

Nature Communications • 20 Sept 2024 • Research

opioidrelapsetreatmentanimal study

Research focus

This article may help explain addiction science through research on opioid, relapse, treatment, animal study. The source abstract begins by describing: “Ibogaine and its main metabolite noribogaine provide important molecular prototypes for markedly different treatment of substance use disorders and co-morbid mental health illnesses.”

Key finding: As such, oxa-iboga compounds represent mechanistically distinct iboga analogs with therapeutic potential.

Why this may help: This may help explain why addiction can involve brain, behavior, mental health, craving, relapse, or treatment factors rather than simple willpower alone. It should be read as research information, not personal medical advice.

Article details

Authors: Václav Havel, Andrew C. Kruegel, Dalibor Sames

DOI: 10.1038/s41467-024-51856-y

Open access: Open Access

Open original source article

Related research topics

Opioid Use Disorder Cravings & Relapse Treatment & Recovery Science

Search similar research

Related article summaries

Acetazolamide inhibition of carbonic anhydrase 4 reverses opioid-induced synaptic rearrangements in nucleus accumbens and reduces drug-seeking behavior

This article may help explain addiction science through research on opioid, cocaine, brain science, withdrawal. The source abstract begins by describing: “Persistent vulnerability to drug-seeking is driven by enduring synaptic adaptations, yet current μ-opioid receptor-targeting pharmacotherapies provide limited efficacy against these neuroadaptations.”

Key finding: By targeting a pathway independent of classical opioid receptor signaling, CA4 inhibition represents a mechanistically distinct strategy that may reduce relapse vulnerability in OUD.

Neuropsychopharmacology • 21 Jan 2026 • Research

opioidcocainebrain sciencewithdrawalrelapsetreatment

Read plain-English summary Open source

Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice

This article may help explain addiction science through research on opioid, brain science, withdrawal, relapse. The source abstract begins by describing: “Opioid use disorder (OUD) is a chronic relapsing disorder that is a major burden for the lives of affected individuals, and society as a whole.”

Key finding: Altogether, these animal models will contribute to study behavioural and neuronal circuitries involved in the several negative affective signs characterizing OUD.

Scientific Reports • 29 Apr 2024 • Research

opioidbrain sciencewithdrawalrelapsemental healthtreatment

Read plain-English summary Open source

Voluntary alcohol intake alters the motivation to seek intravenous oxycodone and neuronal activation during the reinstatement of oxycodone and sucrose seeking

This article may help explain addiction science through research on opioid, alcohol, dopamine, brain science. The source abstract begins by describing: “Opioid-alcohol polysubstance use is prevalent and worsens treatment outcomes.”

Key finding: Thus, alcohol alters the motivation to seek oxycodone in a sex-dependent manner and the neural circuitry engaged by cue-primed reinstatement of sucrose and oxycodone-seeking.

Scientific Reports • 06 Nov 2023 • Research

opioidalcoholdopaminebrain sciencerelapsetreatment

Read plain-English summary Open source

The protective effect of operant social reward on cocaine self-administration, choice, and relapse is dependent on delay and effort for the social reward

This article may help explain addiction science through research on opioid, cocaine, methamphetamine, relapse. The source abstract begins by describing: “Social reinforcement-based treatments are effective for many, but not all, people with addictions to drugs.”

Key finding: This choice procedure can identify mechanisms of individual differences in an animal model of cocaine use and could thereby help screen medications for people who are relatively unresponsive to treatments based on rewarding social interaction.

Neuropsychopharmacology • 16 Aug 2021 • Research

opioidcocainemethamphetaminerelapsegeneticstreatment

Read plain-English summary Open source

Found in translation: orexin receptor antagonism for the treatment of opioid use disorder

This article may help explain addiction science through research on opioid, withdrawal, craving, relapse. The source abstract begins by describing: “Existing pharmacological treatment options for opioid use disorder (OUD) face challenges that limit their efficacy.”

Key finding: This review adopts a translational approach to achieve several aims: (1) to outline the fundamental theories of orexin system function and relate orexinergic dysfunction to the disordered motivation and withdrawal states that characterize OUD; (2) to provide an up-to-date evaluation of preclinical and clinical evidence bases supporting the efficacy of orexin receptor antagonism for the treatment of OUD; (3) to discuss key clinical considerations of repurposing DORAs for OUD treatment, including safety and side effects (i.e., respiratory depression, anhedonia, and risk for abuse); and (4) to highlight the ongoing clinical efforts to determine therapeutic efficacy and safety profiles of DORAs for use in OUD populations.

Translational Psychiatry • 24 Oct 2025 • Reviews

opioidwithdrawalcravingrelapsemental healthtreatment

Read plain-English summary Open source

Important: These pages summarize research information and source article records. They are not medical advice, diagnosis, emergency support, or a replacement for qualified treatment. If someone is in immediate danger, contact local emergency services.